Reflect Scientific, Inc. (RSCF)
OTCMKTS: RSCF · Delayed Price · USD
0.0500
+0.0012 (2.46%)
Apr 26, 2024, 11:17 AM EDT - Market closed
Reflect Scientific Revenue
In the year 2023, Reflect Scientific had annual revenue of $1.08M, a decrease of -47.08%. Revenue in the quarter ending December 31, 2023 was $188.77K, a -60.58% decrease year-over-year.
Revenue (ttm)
$1.08M
Revenue Growth
-47.08%
P/S Ratio
3.75
Revenue / Employee
$154,308
Employees
7
Market Cap
4.05M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.08M | -961.14K | -47.08% |
Dec 31, 2022 | 2.04M | -773.37K | -27.48% |
Dec 31, 2021 | 2.81M | 22.05K | 0.79% |
Dec 31, 2020 | 2.79M | 1.18M | 73.54% |
Dec 31, 2019 | 1.61M | 57.26K | 3.69% |
Dec 31, 2018 | 1.55M | 486.21K | 45.62% |
Dec 31, 2017 | 1.07M | -122.83K | -10.33% |
Dec 31, 2016 | 1.19M | 151.29K | 14.58% |
Dec 31, 2015 | 1.04M | -490.60K | -32.11% |
Dec 31, 2014 | 1.53M | 240.90K | 18.72% |
Dec 31, 2013 | 1.29M | -42.03K | -3.16% |
Dec 31, 2012 | 1.33M | -658.29K | -33.12% |
Dec 31, 2011 | 1.99M | -414.35K | -17.25% |
Dec 31, 2010 | 2.40M | -3.26M | -57.55% |
Dec 31, 2009 | 5.66M | -4.47M | -44.13% |
Dec 31, 2008 | 10.13M | 2.11M | 26.27% |
Dec 31, 2007 | 8.02M | 5.45M | 211.71% |
Dec 31, 2006 | 2.57M | 331.89K | 14.81% |
Dec 31, 2005 | 2.24M | 137.73K | 6.55% |
Dec 31, 2004 | 2.10M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
RSCF News
- 6 months ago - Reflect Scientific Inc. Announces Successful Testing of Liquid Nitrogen Temperature Control Technology - GlobeNewsWire
- 7 months ago - Reflect Scientific Inc. Announces Record-Breaking Freezer Order from a $40B BioPharma Company - GlobeNewsWire
- 9 months ago - Reflect Scientific Secures $200,000 Order from Prominent Bio-Pharma Client for Blast Freezers - GlobeNewsWire
- 10 months ago - Reflect Scientific Inc Receives Order for B-90 Plasma Freezer, Continues to Expand Clientele - GlobeNewsWire
- 1 year ago - Reflect Scientific Inc Reports First Quarter 2023 Results - GlobeNewsWire
- 1 year ago - Reflect Scientific Inc Announces Year-End Financial Results for 2022 - GlobeNewsWire
- 1 year ago - Reflect Scientific Inc. Releases Third Quarter 2022 Financials - GlobeNewsWire
- 1 year ago - Reflect Scientific Inc. Releases Second Quarter 2022 Financials - GlobeNewsWire